| |
 |
|
|
Inventor: Williamson; Mark
Address: Saugus, MA
No. of patents: 21
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7288392 |
Human protein kinases and uses therefor |
October 30, 2007 |
| The invention relates to novel kinase nucleic acid sequences and proteins. Also provided are vectors, host cells, and recombinant methods for making and using the novel molecules. |
| 7282360 |
Human protein kinase, phosphatase, and protease family members and uses thereof |
October 16, 2007 |
| The invention provides isolated nucleic acids molecules, designated 53070, 15985, 26583, 21953, m32404, 14089, and 23436 nucleic acid molecules, which encode novel human protein kinase family members, serine/threonine protein kinase family members, serine/threonine phosphatase family |
| 7214374 |
12832, a novel human kinase-like molecule and uses thereof |
May 8, 2007 |
| Novel human kinase-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length kinase-like proteins, the invention further provides isolated kinase-like fusion proteins, antigenic peptides, and anti-kinase-like antibodies. The invention als |
| 7070947 |
Human protein kinase, phosphatase, and protease family members and uses thereof |
July 4, 2006 |
| The invention provides isolated nucleic acids molecules, designated 2504, 15977, 14760, 53070, 15985, 50365, 26583, 21953, m32404, 14089, and 23436 nucleic acid molecules, which encode novel human protein kinase family members, serine/threonine protein kinase family members, hexokinase |
| 7045325 |
32142, 21481, 25964, 21686, novel dehydrogenase molecules and uses therefor |
May 16, 2006 |
| The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, |
| 7034111 |
17867, a novel human aminopeptidase |
April 25, 2006 |
| The present invention relates to a newly identified human aminopeptidase. The invention also relates to polynucleotides encoding the aminopeptidase. The invention further relates to methods using the aminopeptidase polypeptides and polynucleotides as a target for diagnosis and treatm |
| 6780627 |
22438, 23553, 25278, and 26212 novel human sulfatases |
August 24, 2004 |
| The present invention relates to newly identified human sulfatases. In particular, the invention relates to sulfatase polypeptides and polynucleotides, methods of detecting the sulfatase polypeptides and polynucleotides, and methods of diagnosing and treating sulfatase-related disord |
| 6767727 |
22438, 23553, 25278, and 26212 novel human sulfatases |
July 27, 2004 |
| The present invention relates to newly identified human sulfatases. In particular, the invention relates to sulfatase polypeptides and polynucleotides, methods of detecting the sulfatase polypeptides and polynucleotides, and methods of diagnosing and treating sulfatase-related disord |
| 6723498 |
Chk1 and uses thereof |
April 20, 2004 |
| Increased expression of Chk1 is associated with drug resistance of certain cells (e.g., cancer cells). The invention provides methods for identifying drug resistant cells by measuring the expression or activity of Chk1, methods for identifying modulators of drug resistance, and methods f |
| 6689865 |
Nucleic acid molecules encoding DRT111 and uses thereof |
February 10, 2004 |
| Novel DRT111 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to an isolated, full-length DRT111 protein, the invention further provides isolated DRT111 fusion proteins, antigenic peptides and anti-DRT111 antibodies. The invention also provides DRT111 nuc |
| 6673564 |
Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
January 6, 2004 |
| The present invention relates to methods for using a human cyclic nucleotide phosphodiesterase belonging to the superfamily of mammalian phosphodiesterases. The invention also relates to methods for using polynucleotides encoding the phosphodiesterase. The invention relates to method |
| 6656698 |
12832, a novel human kinase-like molecule and uses thereof |
December 2, 2003 |
| Novel human kinase-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length kinase-like proteins, the invention further provides isolated kinase-like fusion proteins, antigenic peptides, and anti-kinase-like antibodies. The invention als |
| 6638721 |
Human protein kinases and uses therefor |
October 28, 2003 |
| The invention relates to novel kinase nucleic acid sequences and proteins. Also provided are vectors, host cells, and recombinant methods for making and using the novel molecules. |
| 6627423 |
21481, a novel dehydrogenase molecule and uses therefor |
September 30, 2003 |
| The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, |
| 6613555 |
32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor |
September 2, 2003 |
| The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, |
| 6544735 |
Methods for identifying candidate inhibitors of drug resistance |
April 8, 2003 |
| Novel DRT111 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to an isolated, full-length DRT111 protein, the invention further provides isolated DRT111 fusion proteins, antigenic peptides and anti-DRT111 antibodies. The invention also provides DRT111 nuc |
| 6534302 |
22438, 23553, 25278, and 26212 novel human sulfatases |
March 18, 2003 |
| The present invention relates to newly identified human sulfatases. In particular, the invention relates to sulfatase polypeptides and polynucleotides, methods of detecting the sulfatase polypeptides and polynucleotides, and methods of diagnosing and treating sulfatase-related disord |
| 6500657 |
33167, a novel human hydrolase and uses therefor |
December 31, 2002 |
| The invention provides isolated nucleic acids molecules, designated HYDL-1 nucleic acid molecules, which encode novel hydrolase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing HYDL-1 nucleic acid molecules, host cells |
| 6369210 |
22012, human carboxypeptidase |
April 9, 2002 |
| The present invention relates to a newly identified human carboxypeptidase. The invention also relates to polynucleotides encoding the carboxypeptidase. The invention further relates to methods using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and |
| 6362324 |
17867 a novel human aminopeptidase |
March 26, 2002 |
| The present invention relates to a newly identified human aminopeptidase. The invention also relates to polynucleotides encoding the aminopeptidase. The invention further relates to methods using the aminopeptidase polypeptides and polynucleotides as a target for diagnosis and treatment |
| 6111092 |
Nucleic acid molecules encoding DRT111 and uses thereof |
August 29, 2000 |
| Novel DRT111 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to an isolated, full-length DRT111 protein, the invention further provides isolated DRT111 fusion proteins, antigenic peptides and anti-DRT111 antibodies. The invention also provides DRT111 nuc |
|
|
|